Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M89.6Revenue (TTM) $M2.5Net Margin (%)-1,623.1Altman Z-Score-34.9
Enterprise Value $M96.1EPS (TTM) $-3.0Operating Margin %-1,570.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,623.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-31.8Quick Ratio2.4Cash flow > EarningsY
Price/Sales23.45-y EBITDA Growth Rate %-6.9Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-115.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-289.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M20.9ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SNSS is held by these investors:



SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.8710.85view
Parker Geoffrey M.Director 2016-12-09Buy3,740$3.8710.85view
Parker Geoffrey M.Director 2016-05-26Buy1,583$2.8252.13view
Parker Geoffrey M.Director 2016-05-25Buy8,751$2.8252.13view
Misfeldt DaytonDirector 2015-12-21Buy291,667$5.04-14.88view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy4,167$6.06-29.21view
Ketchum Steven BDirector 2015-07-24Sell1,060$20.76-79.34view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell1,060$20.76-79.34view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell2,119$20.76-79.34view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell105,951$20.76-79.34view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4 Feb 24 2017
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line Feb 23 2017
Pfizer's Leukemia Candidate Gets Priority Review in U.S. Feb 22 2017
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View Feb 17 2017
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y Feb 16 2017
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4 Feb 15 2017
AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates Feb 15 2017
The Zacks Analyst Blog Highlights: Celgene, Cellectis S.A., Exelixis, Exact Sciences and Sunesis... Feb 08 2017
5 Great Biotech Stocks to Buy Now Feb 07 2017
Mallinckrodt (MNK) Tops on Earnings in Transition Quarter Feb 07 2017
Sunesis Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017
Novartis (NVS) Votubia Gets EU Approval for Label Expansion Feb 02 2017
Endo's (ENDP) Ephedrine Sulfate Injection Gets FDA Approval Jan 31 2017
Eli Lilly (LLY) Misses on Q4 Earnings, Beats on Revenues Jan 31 2017
Novo Nordisk Inks Diabetes Deal with University of Oxford Jan 30 2017
Endo (ENDP) Restructures Branded Pharmaceutical Unit (revised) Jan 30 2017
Celgene (CELG) Gets Favorable CHMP Opinion for Revlimid Jan 30 2017
Protalix BioTherapeutics (PLX) Jumps: Stock Rises by 11.7% Jan 30 2017
AstraZeneca's Symbicort Granted Pediatric Exclusivity by FDA Jan 27 2017
Immunogen Doses First Patient in Ovarian Cancer Drug Study Jan 27 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)